Zu den Inhalten springen

Tumorzentrum Freiburg - CCCF

DKTK

German Cancer Consortium - Deutsches Konsortium Translationale Krebsforschung

German Cancer Consortium (DKTK) is a joint initiative involving the German Federal Ministry of Education and Research (BMBF), participating German states, German Cancer Aid and the German Cancer Research Center (DKFZ). It was established in October 2012 as one of six German Health Research Centres (DZGs).

Within DKTK, cancer researchers and medical practitioners collaborate closely at eight locations across Germany: Berlin, Dresden, Essen/Düsseldorf, Frankfurt/Mainz, Freiburg, Heidelberg, Munich and Tübingen.

The aim is to speed up the transfer to clinical practice of new diagnostic and treatment approaches. Translating innovations quickly from basic research into clinical practice is the core task of DKTK.

To learn more about DKTK translational research programs and platforms, opportunities for young scientists, events and news, visit the DKTK webpage.

 

The third funding period of DKTK is going to start in 2021 and the main scientific activities of DKTK Freiburg will be performed in three focus areas:

  • Epigenetic & Oncogenic Signaling
  • Imaging, Biomarker Identification & Radiation Therapy
  • Functional & Translational Genomics

We are looking for innovative ideas and projects that enrich these focus topics and invite translational researchers and clinician scientists in Freiburg to apply for the funding in the field of translational cancer research.

The call is open to researchers and clinicians from member departments of the Comprehensive Cancer Center Freiburg – CCCF (Medical Center – University of Freiburg) and local DKTK scientists, working in the field of translational cancer research, who have already or intend to set up their own research group.

The call is open to junior and advanced scientists from the postdoctoral level onwards, but excluding W3 professors acting as department heads (W3 Professur mit Leitungsfunktion) or equivalent.

Young scientists are especially encouraged to apply.

 

The total available budget for all projects in the three focus areas is approx. € 1.3 M. per year. Estimated funds for a single application should be between € 100.000-200.000 per year.

Expected project start: January 1st, 2021.

Funding will be initially granted for three years with the possibility of two years extension.

Application deadline: November 1st , 2020

For more information, please find attached the “General Information” and “Application Form” for the call.

 

If you have further questions regarding the call, please contact coordination office DKTK in Freiburg:

Dr. Anja Hernandez (administrative coordinator): anja.hernandez@dkfz-heidelberg.de

Dr. Anna Dost (scientific coordinator): a.dost@dkfz-heidelberg.de

Prof. Dr. Christoph Peters (spokesperson of DKTK Freiburg): christoph.peters@mol-med.uni-freiburg.de

 

-- Logo: © dkfz.de


 

Prof. Dr. Christoph Peters
Tumorzentrum Freiburg CCCF
Phone: +49-761-270-71500
Hugstetter Str. 49
79106 Freiburg

and

Institute of Molecular Medicine and Cell Research
University of Freiburg
Stefan-Meier-Str. 17
79104 Freiburg
Phone: +49-761-203-9600/9601
christoph.peters@mol-med.uni-freiburg.de​​

Dr. Anja Hernández
Deutsches Krebsforschungszentrum (DKFZ)
Im Neuheimer Feld 280
69120 Heidelberg
++49 (0)761 270 22810
anja.hernandez@dkfz-heidelberg.de

Dr. Anna Dost
Deutsches Krebsforschungszentrum (DKFZ)
Im Neuheimer Feld 280
69120 Heidelberg
+49 (0)761 270 77121
a.dost@dkfz-heidelberg.de